Sabra Health Care (SBRA) Soars 1.29% Despite Downgrade

Sabra Health Care (SBRA) has surged by 1.29%, marking its third consecutive day of gains, with a cumulative increase of 3.43% over the past three days.

Over the past five years, the strategy of buying SBRA shares after they reached a recent None and holding for one week yielded a 27.62% return, slightly underperforming the benchmark's 41.02% return. The strategy's Sharpe ratio was 0.54, with a maximum drawdown of -19.03% and a volatility of 20.41%, indicating a moderate risk-adjusted return and significant volatility.

Sabra Health Care REIT's stock price was recently impacted by a downgrade from Truist. The downgrade changed the stock's rating from "buy" to "hold" and reduced its price target to $17, leading to a decrease in its shares during Friday trading.